A strategic partnership to further research into traditional Chinese medicine has been signed by the University of Nottingham and Tasly Group, one of China's largest pharmaceutical companies and a world leader in creating modern drugs from ancient Chinese remedies. Henry Sun, vice-president of Tasly, said the company would like to collaborate with the university "at all levels", from research and development through to regulatory approval and commercialisation. "There are many ways in which our experience can contribute to Nottingham's ongoing research in traditional Chinese medicine," he said.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber? Login